Cisplatin-loaded graphene oxide/chitosan/hydroxyapatite composite as a promising tool for osteosarcoma-affected bone regeneration by Subbiah, Suresh Kumar et al.
Cisplatin-loaded graphene oxide/chitosan/hydroxyapatite composite as a promising tool 
for osteosarcoma-affected bone regeneration 
 
ABSTRACT 
Presently, tissue engineering approaches have been focused toward finding new potential 
scaffolds with osteoconductivity on bone-disease-affected cells. This work focused on the 
cisplatin (CDDP)-loaded graphene oxide (GO)/hydroxyapatite (HAP)/chitosan (CS) composite 
for enhancing the growth of osteoblast cells and prevent the development of osteosarcoma 
cells. The prepared composites were characterized for the confirmation of composite formation 
using Fourier transform infrared spectroscopy, scanning electron microscopy, transmission 
electron microscopy, and X-ray diffraction techniques. A flowerlike morphology was observed 
for the GO/HAP/CS-3/CDDP composite. UV−vis spectroscopy was used to observe the 
controlled release of CDDP from the GO/HAP/CS-3/CDDP composite, and 67.34% of CDDP 
was released from the composite over a time period of 10 days. The GO/HAP/CS-3/CDDP 
nanocomposites showed higher viability in comparison with GO/HAP/CS-3 on MG63 
osteoblast-like cells and higher cytotoxicity against cancer cells (A549). The synthesized 
composite was found to show enhanced proliferative, adhesive, and osteoinductive effects on 
the alkaline phosphatase activity of osteoblast-like cells. Our results suggested that the CDDP-
loaded GO/HAP/CS-3 nanocomposite has an immense prospective as a bone tissue 
replacement in the bone-cancer-affected tissues. 
